Indications and uses
relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours
relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours
Dose once daily take with 6 to 8 oz of milk, juice or infant formula to mask the bitter taste. adults and children 12 years and older 5 to 20 mL (1 to 4 teaspoonfuls) children 6 to under 12 years of age 5 to 10 mL (1 to 2 teaspoonfuls) children 3 to under 6 years of age 2.5 to 5 mL (1/2 to 1 teaspoonful) children under 3 years ask a doctor
(in each 5 mL)
Docusate sodium 100 mg
Stool softener
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years and older | 5 to 20 mL (1 to 4 teaspoonfuls) |
| children 6 to under 12 years of age | 5 to 10 mL (1 to 2 teaspoonfuls) |
| children 3 to under 6 years of age | 2.5 to 5 mL (1/2 to 1 teaspoonful) |
| children under 3 years | ask a doctor |
NDC 0904-7279-66: 10 mL unit dose cup, in a tray of ten cups.
artificial cherry vanilla flavoring, citric acid anhydrous, D&C Red No. 33, glycerin, methylparaben, polyethylene glycol, propylene glycol, propylparaben, purified water, saccharin sodium, sodium citrate, and sorbitol
Call 1-800-845-8210
R06/22
MAJOR® PHARMACEUTICALS
Indianapolis, IN 46268
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1245686 | docusate sodium 50 MG in 5 mL Oral Solution | PSN | 9 |
| 1245686 | docusate sodium 10 MG/ML Oral Solution | SCD | 9 |
| 1245686 | docusate sodium 10 MG per 1 ML Oral Solution | SY | 9 |
| 1245686 | docusate sodium 100 MG per 10 ML Oral Solution | SY | 9 |
| 1245686 | docusate sodium 150 MG per 15 ML Oral Solution | SY | 9 |
| 1245686 | DOSS Sodium 10 MG/ML Oral Solution | SY | 9 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0904-7279-66 | Docusate Sodium | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | 9 | |
| 0904-7279-72 | Docusate Sodium | 10 in 1 CASE | LIQUID | 10 | 9 | |
| 0904-7279-72 | Docusate Sodium | 10 in 1 TRAY | LIQUID | 10 | 9 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-7279-66 | ML - Milliliter | 0904-7279 | 5e379c79-f91f-4982-9da6-7d3385d90c52 | 1 | 2023-01-09 |
| 0904-7279-72 | ML - Milliliter | 0904-7279 | 3890c02c-4787-4857-aaa4-677b71ce30d8 | 1 | 2023-01-09 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0904-7279 | 0904-7279-66, 0904-7279-72 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DOCUSATE SODIUM | F05Q2T2JA0 | ACTIB |
| CITRIC ACID | 2968PHW8QP | IACT |
| RED 33 | 9DBA0SBB0L | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
| SODIUM CITRATE, UNSPECIFIED FORM | 1Q73Q2JULR | IACT |
| SORBITOL | 506T60A25R | IACT |
| WATER | 059QF0KO0R | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docusate Sodium | DOCUSATE SODIUM | Major Pharmaceuticals | 1541ff5b-11f8-444b-a2a0-8e3086ae650a | 2025-01-10 | Warnings | 0904-7279-66 0904-7279-72 0904-7279 00904727972 00904727966 ac88d5b7-192e-456b-ae3e-3813294d4617 1541ff5b-11f8-444b-a2a0-8e3086ae650a |
Adverse event summaries are temporarily unavailable. Other product information remains available.